H. RALPH SNODGRASS - PRES./CHIEF SCIENTIFIC OFFICER at Vistagen Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Pres./Chief Scientific Officer
Issuer Symbol
VTGN on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by H. RALPH SNODGRASS since 10 Feb 2025

Holdings reported by H. RALPH SNODGRASS for Vistagen Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 64,958 $111,533 $1.72 31 Dec 2021 Direct
Common Stock 33,901 $58,208 $1.72 31 Dec 2021 By H. Ralph Snodgrass Living Trust, dated 10/2/2008

Transactions reported by H. RALPH SNODGRASS for Vistagen Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.